Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» felzartamab
felzartamab
Biogen shows its IgAN hand with felzartamab data
Pharmaphorum
Mon, 10/28/24 - 10:19 am
Biogen
clinical trials
kidney disease
felzartamab
IgA nephropathy
Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients
Drugs.com
Sun, 10/13/24 - 11:30 am
Biogen
felzartamab
FDA
breakthrough therapy
kidney transplants
HI-Bio's expectations elevated after pair of phase 2 readouts bolster autoimmune ambitions
Fierce Biotech
Tue, 04/11/23 - 11:36 am
Hi-Bio
Human Immunology Bioscience
kidney disease
felzartamab